摘要 |
<p>The use of an alkanoyl-L-carnitine, e.g. acetyl-L-carnitine, or a pharmacologically acceptable salt thereof is disclosed to produce a medicament for the therapeutic treatment or prophylaxis of glutamate-mediated cytological disturbances or diseases.</p> |